AntiCoagulation Europe (UK)

AntiCoagulation Europe (UK)

ABOUT US

Contact us

ANTIPLATELET THERAPY

Educational Films

Pulmonary Embolism


What is a pulmonary embolism?

A pulmonary embolism (PE) is a blood clot in the lung. It usually comes from smaller vessels in the leg. Clots forming in the legs are called deep vein thrombosis (DVT).

The clot travels to the lungs and then through the vessels of the lung until it reaches smaller vessels where it becomes wedged. The clot then prevents any further blood from travelling to that section of the lung.

Common symptoms might include:

  • Chest pain that is sharp and is worse when taking a deep breath
  • Shortness of breath
  • Sweating

All the above can also be symptoms for other conditions; however pulmonary embolism can be life threatening so if you are concerned seek the advice of a doctor or go to the nearest accident and emergency department.


Treatment

  • Heparin is usually the first medication given. It will stop further clots forming. It may be given by an intravenous drip or low molecular weight heparin may be given by injection.
  • Warfarin (Coumadin) is usually given shortly after the heparin or a low molecular weight heparin is started. Both of these will be continued until blood tests show that the warfarin is adequately thinning the blood. Once this is shown, then the heparin is stopped, and the warfarin is continued.Image: nurse and patient

People with PEs may be in hospital for several days until their blood can be adequately thinned. Then they are maintained on blood thinning medication for six months or longer.

 

 

anticoagulation@ntlworld.com

Copyright AntiCoagulation Europe 2006
Registered Charity No 1090250

Text too small? Click here.

AntiCoagulation Europe, PO Box 405, Bromley, Kent BR2 9WP | Tel: 020 8289 6875


PLEASE NOTE THIS WEBSITE SHOULD NOT BE USED TO REPLACE ADVICE FROM YOUR DOCTOR


We welcome feedback about our website. Please email your comments to
anticoagulation@ntlworld.com

 

Contact us by email

 

Contact us by post, phone or fax

 

What is atrial fibrillation?

 

About Cardioversion

 

ABout Ablation

 

Lionel

 

TIPS TO HELP YOU AVOID A DVT

 

TRAVELLER'S THROMBOSIS

 

Stress and heart disease

 

Medical Alert identity Card

 

MARIANNE GILL

 

John Kelman

 

MICHAEL KNIGHT

 

Evelyn Richardson

 

Max Crompton

 

1. Introduction

 

2. Overview

 

3. How to Roll out a near-patient testing service in Primary care

 

4. The importance of quality control and assurance and Selecting a POC device

 

5. Rolling out a Patient self-testing service

 

6. The patient's perspective

 

7. A personal account

 

8. Conclusion

 

European Medicines agency recommends approval of Dabigatran etexilate

 

UNipath withdraws smartchek

 

A guide to setting up Near Patient Testing in Primary Care

 

NICE guidelines for atrial fibrillation

 

Near patient Testing in Tayside

 

Patients capable of self-testing: a systematic review

 

European Medicines agency recommends approval of Dabigatran etexilate

 

UNipath withdraws smartchek

 

NICE guidance on Venous Thromboembolism (VTE)

 

Venous thromboembolism CMO press release

 

Front Line in Stroke Prevention - Report

 

New hope for early detection of deep vein thrombosis

 

NICE guidelines for atrial fibrillation

 

Ongoing trials for new oral anticoagulant

 

Expert pharmacists get the go-ahead

 

Patients capable of self-testing: a systematic review

 

News archive

 

'Strips on prescription' resource pack

 

Abolition of prescription charges

 

Equality for the Republic of Ireland

 

It's about time

 

It's about time survey

 

conference for health care professionals: Improving patient Safety and Managing Risks Associated with Anticoagulation Therapy

 

Conference 2008

 

Flora London MArathon 2008

 

CoaguNation Bus Tour

 

Roche Diagnostics launches CoaguNation Club

 

INR Test Monitors

 

Breaking news